- August 17, 2026
- By Dr. Sarah Thompson, PharmD
Metronidazole is a dual-action antimicrobial medicine prescribed for susceptible anaerobic bacterial infections and several protozoal infections, including bacterial vaginosis, trichomoniasis, giardiasis and amebiasis, and Canadian patients can obtain oral prescription products containing this active ingredient in commonly used 250 mg and 500 mg strengths, although the familiar Flagyl name now represents only part of a broader metronidazole market in which the exact brand, dosage form, treatment duration and pharmacy price depend on the condition being treated and the product dispensed.
| Quick fact | Information |
|---|---|
| Active ingredient | Metronidazole |
| Well-known brand | Flagyl |
| Drug class | Nitroimidazole antibacterial and antiprotozoal |
| Prescription required in Canada | Yes |
| Common oral strengths | 250 mg and 500 mg |
| Can it treat viral infections? | No |
| Other dosage forms | Vaginal, topical and intravenous products also exist |
Can You Get Metronidazole in Canada?
Metronidazole is available through the ordinary Canadian prescription-drug system and does not require a special-access pathway. Health Canada’s Drug Product Database includes marketed oral products such as MINT-Metronidazole 250 mg tablets and M-Metronidazole 500 mg capsules, both classified as prescription medicines.
The Flagyl name needs some explanation because a patient searching specifically for “Flagyl tablets” may encounter information from several periods of the Canadian market. Current Health Canada records contain metronidazole products from different manufacturers, while the present Sanofi Flagyl product information in Canada covers a vaginal formulation. The active ingredient therefore remains available even when the oral medicine supplied by a pharmacy does not carry the Flagyl name.
This distinction matters when a prescription states simply “metronidazole.” Depending on strength and pharmacy inventory, the patient may receive a product from Mint Pharmaceuticals, Mantra Pharma, Apotex or another authorized manufacturer instead of a package carrying the Flagyl brand.
Health Canada assigns marketed drug products a Drug Identification Number, or DIN, which allows a pharmacy, insurer and patient to identify the exact authorized formulation.
Metronidazole remains a prescription medicine. A patient should therefore expect an appropriate prescription before an oral course is dispensed. Pharmacy practice itself is regulated provincially and territorially, so the pharmacy responsible for dispensing follows the requirements of its own jurisdiction.
The main distinction for patients is that Metronidazole availability and Flagyl brand availability are not the same question. A pharmacy may have an authorized 250 mg or 500 mg metronidazole product available even when an oral package branded Flagyl is not the product being dispensed.
How Much Does Treatment Cost?
Metronidazole illustrates the difference between a public formulary ingredient price and the final amount a patient may pay at a pharmacy.
Ontario’s Drug Benefit Formulary lists some 250 mg metronidazole tablets at approximately C$0.06 per tablet, while several 500 mg interchangeable products are listed at approximately C$0.27 per unit. These are formulary ingredient prices, not guaranteed retail totals, because dispensing fees, public-plan eligibility, deductibles and private insurance can substantially change the final cost.
| Example regimen | Approx. ingredient cost based on listed unit prices |
|---|---|
| 250 mg twice daily for 5 days, 10 tablets | About C$0.60 |
| 250 mg twice daily for 7 days, 14 tablets | About C$0.80 |
| 500 mg twice daily for 7 days, 14 capsules | About C$3.80 |
| 500 mg every 8 hours for 7 days, 21 capsules | About C$5.75 |
A dispensing fee can exceed the ingredient cost of a short metronidazole course, which is why comparing only the tablet price can produce a misleading estimate of what the patient will actually pay.
Canada-oriented online pharmacy services show substantially higher consumer prices. Current international listings can place 14 tablets of 250 mg at approximately US$20–25, while 14 units of a 500 mg product can also fall around the mid-US$20 range. Larger packages can have a much lower unit price but may cost US$30, US$60 or more depending on strength, manufacturer and dispensing country.
Online figures should be treated as advertised retail examples rather than official Canadian pharmacy prices because these services may use different currencies, supply chains and fulfillment locations.
When comparing prices, patients should check:
- tablet or capsule strength;
- number of doses supplied;
- manufacturer;
- currency;
- dispensing fee;
- shipping cost;
- country from which the medicine is dispensed;
- public or private insurance coverage.
A package containing 100 tablets may have an attractive unit price but be unnecessary for an infection treated with 10, 14 or 21 doses. Leftover antibiotic tablets should not be treated as a supply for future infections because another episode may require a different drug, strength or duration.
Can Flagyl Be Ordered Online?
Metronidazole can be dispensed through legitimate online pharmacy services, although its prescription status remains unchanged. Ordering through a website does not convert a prescription antimicrobial into an over-the-counter product.
A Canadian online pharmacy should provide enough information for the dispensing pharmacy to be checked with the provincial or territorial pharmacy regulatory authority responsible for its location. A Canadian flag, maple-leaf logo or Canadian domain name does not independently establish pharmacy licensure.
Before completing an online order, a patient should be able to determine:
- the legal name of the dispensing pharmacy;
- its physical location;
- the pharmacy regulator responsible for that location;
- whether a valid prescription is required;
- the exact strength and dosage form;
- manufacturer when available;
- quantity supplied;
- country from which the order will be dispensed;
- whether a pharmacist can be contacted;
- total medication and shipping cost.
International fulfillment creates another distinction. Some Canada-oriented prescription services work with partner pharmacies in several countries, so a website operated from Canada can list metronidazole manufactured or dispensed elsewhere. Patients should therefore check both the manufacturer and actual dispensing country.
Canadian residents also need to distinguish domestic online dispensing from importing prescription drugs into Canada. Canadian personal-importation rules generally restrict residents from receiving prescription medicines by mail or courier from outside the country except under defined circumstances.
Americans using Canada-oriented pharmacy services face U.S. import requirements instead. FDA personal-importation policy does not provide a general legal entitlement to order any prescription drug from another country, even when the quantity represents a personal supply.
The pharmacy’s willingness to accept an order and the destination country’s willingness to permit the shipment are therefore separate questions.
What Is Metronidazole Used For?
Metronidazole has an unusual therapeutic profile because it acts against certain anaerobic bacteria and certain protozoa. It is therefore described as both an antibacterial and an antiprotozoal medicine.
Oral metronidazole is used in several distinctly different clinical settings, including:
- bacterial vaginosis;
- trichomoniasis caused by Trichomonas vaginalis;
- giardiasis;
- intestinal and hepatic amebiasis;
- anaerobic intra-abdominal infections;
- some abscesses and other infections involving susceptible anaerobic bacteria;
- mixed infections where metronidazole is combined with another antibiotic for broader coverage.
Metronidazole does not provide general antibacterial coverage for every infection. Its antibacterial activity is particularly relevant to anaerobic organisms, while many aerobic bacteria require another antimicrobial agent.
The medicine also does not treat viral infections. Influenza, a common cold and other viral respiratory illnesses will not respond to metronidazole.
The distinction becomes especially important when gastrointestinal symptoms are involved. Diarrhea can result from viruses, bacteria, protozoa, inflammatory bowel disease, medication effects and numerous noninfectious disorders. The fact that metronidazole can treat Giardia or amebiasis does not make it a universal medicine for diarrhea after travel.
Bacterial vaginosis and trichomoniasis provide another useful comparison. Both can produce vaginal symptoms and both can involve metronidazole treatment, yet bacterial vaginosis represents disruption of vaginal bacterial flora while trichomoniasis is a sexually transmitted protozoal infection. Diagnosis, partner management and follow-up are therefore different.
Unnecessary treatment should also be avoided because metronidazole remains an antimicrobial medicine. The decision to prescribe it should be based on a diagnosed or sufficiently suspected susceptible infection instead of nonspecific symptoms alone.
Which Forms and Strengths Are Available?
Patients searching for “Flagyl” can encounter tablets, capsules, vaginal products, topical gels and intravenous metronidazole, although these formulations serve different purposes and should not be treated as interchangeable.
Current Canadian oral products include 250 mg tablets and 500 mg capsules. Different manufacturers can supply the same active ingredient under their own product names.
| Form | Example strength | Typical context |
|---|---|---|
| Oral tablet | 250 mg | Systemic bacterial or protozoal treatment |
| Oral capsule | 500 mg | Systemic treatment |
| Vaginal Flagyl cream | 10% | Local vaginal treatment |
| Topical gel | 0.75% or 1% | Dermatologic use, including rosacea |
| Intravenous formulation | Expressed in mg/mL | Hospital treatment of significant infections |
The current Canadian Flagyl-branded product includes a 10% vaginal cream, with one full applicator delivering 500 mg of metronidazole. This dosage form should be distinguished from an oral 500 mg product because the route of administration and therapeutic use are different.
Topical metronidazole belongs to another treatment setting. Products such as metronidazole gel can be prescribed for rosacea and other dermatologic indications. Applying topical gel does not provide the systemic exposure required for giardiasis or a significant internal anaerobic infection.
The same principle applies to vaginal formulations. A locally administered preparation cannot be substituted milligram-for-milligram for an oral prescription simply because both contain metronidazole.
Online buyers should therefore compare the route, concentration, strength and dosage form before comparing price.
How Is Metronidazole Taken?
There is no single Flagyl dose appropriate for every infection. The organism, infection site, severity, patient age, liver function and use of other antimicrobials can all change the regimen.
| Condition | Example oral regimen |
|---|---|
| Bacterial vaginosis | 500 mg twice daily for 7 days |
| Trichomoniasis | 2 g as a single oral dose in one established regimen |
| Giardiasis in adults | 250 mg twice daily for 5–7 days |
| Intestinal amebiasis | 750 mg three times daily for 5–7 days |
| Amebic liver abscess | 500–750 mg three times daily for 5–7 days |
| Selected serious anaerobic infections | 500 mg every 8 hours when oral therapy is appropriate |
These are examples of established regimens and should not be used as instructions for self-treatment. The prescription label remains the relevant dosing instruction for the individual patient.
Many adult oral courses fall within a range of approximately 250-500 mg every 8 to 12 hours for 5-10 days, although some infections use a single larger dose and others require substantially higher daily exposure.
Food instructions can differ by regimen. Patients experiencing nausea may find oral metronidazole easier to tolerate with food when this is consistent with the dispensing instructions. Some high single-dose regimens are specifically administered after a meal.
If a dose is forgotten, it can generally be taken when remembered unless the next scheduled dose is approaching. Two doses should not be taken together simply to compensate for a missed tablet.
Improvement before the final scheduled dose also does not mean that the remaining treatment can automatically be stopped. The prescribed course should be completed unless the healthcare professional changes the treatment or an adverse reaction requires another response.
Why Alcohol Is a Special Concern?
Alcohol is one of the best-known precautions associated with metronidazole, and Canadian product information continues to recommend avoiding it during oral treatment.
Alcohol should generally be avoided throughout the course and for at least one day after the final dose according to Canadian oral product information. The combination can be associated with nausea, vomiting, abdominal discomfort, flushing, headache and rapid or irregular heartbeat.
The instruction is relevant to more than beer, wine and spirits. Alcohol-containing liquid medicines or other preparations can also contribute to exposure during treatment.
Patients may encounter different post-treatment intervals on foreign medicine labels. The directions supplied with the specific prescription should therefore be followed instead of combining several countries’ recommendations.
Nausea, abdominal discomfort and headache can already occur as adverse effects of metronidazole itself. Alcohol use during treatment can make these symptoms more difficult to interpret and may increase discomfort.
A patient who accidentally consumes alcohol and develops substantial vomiting, palpitations, marked weakness or another significant reaction should obtain clinical advice according to the severity of the symptoms.
What Side Effects and Warning Signs Matter?
A metallic or otherwise unpleasant taste is one of the characteristic complaints associated with oral metronidazole. Gastrointestinal symptoms are also sufficiently common that patients may notice them during a multi-day course.
Reported effects include:
- nausea;
- vomiting;
- upset stomach;
- abdominal discomfort;
- loss of appetite;
- constipation;
- metallic or unpleasant taste;
- dry mouth;
- coated or discoloured tongue;
- headache;
- dizziness;
- drowsiness;
- flushing;
- itching, hives or rash;
- darkened urine.
Dark urine can appear alarming, but metronidazole metabolites can produce urine discoloration without indicating a dangerous reaction by themselves.
Dark urine accompanied by yellowing of the skin or eyes, pale stool, substantial upper abdominal pain or severe weakness deserves a different evaluation because those findings may indicate liver dysfunction.
The neurologic safety profile becomes particularly relevant during prolonged or high-dose therapy. Peripheral neuropathy can cause:
- tingling;
- numbness;
- burning sensations;
- altered sensation in the hands or feet.
Other reported neurologic effects include seizures, impaired coordination, confusion, vertigo and visual disturbances.
More serious warning signs include:
- swelling of the face, tongue or throat;
- difficulty breathing;
- severe or blistering rash;
- persistent severe diarrhea;
- new numbness or significant tingling;
- problems with coordination;
- seizure;
- marked confusion or hallucinations;
- yellowing of the skin or eyes;
- severe upper abdominal pain;
- major visual changes.
Rare severe skin reactions have been reported, including Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS.
Serious liver toxicity is another uncommon concern. Particular attention is required in people with Cockayne syndrome because severe hepatotoxicity has been reported in this patient group.
The duration of treatment changes the risk profile. A standard five- or seven-day course represents a different exposure from repeated or prolonged treatment lasting several weeks.
Who Should Take Extra Precautions?
Metronidazole requires additional assessment in several medical situations because liver function, neurologic disease, blood disorders and other conditions can alter its safety profile.
Important information to discuss with the prescriber includes:
- allergy to metronidazole or another nitroimidazole medicine;
- liver disease;
- significant kidney impairment;
- previous neurologic disease;
- seizures;
- peripheral neuropathy;
- previous blood-cell abnormalities;
- Cockayne syndrome;
- pregnancy;
- breastfeeding;
- prolonged or repeated metronidazole treatment;
- use of medicines with important interaction potential.
Severe liver disease can reduce metronidazole metabolism and increase systemic exposure. Dose modification or additional monitoring may therefore be appropriate depending on the degree of hepatic impairment and treatment being used.
Kidney impairment affects treatment differently. Metronidazole itself may not accumulate to the same degree, although metabolites can build up in severe renal impairment, particularly when dialysis is not removing them.
Pregnancy requires an individualized assessment. Metronidazole crosses the placenta, and Canadian oral product information advises particular caution during the first trimester. Use later in pregnancy should take into account the infection, expected maternal benefit and available alternatives.
Breastfeeding should also be discussed because metronidazole passes into human milk. The importance of this exposure depends on the dose, duration, route of administration and clinical indication.
Which Medicines Can Interact With Metronidazole?
Metronidazole has several clinically important drug interactions, which makes a medication review useful even when the antibiotic course lasts only a few days.
Warfarin is one of the most important examples. Metronidazole can increase the anticoagulant effect of warfarin, potentially increasing INR and bleeding risk. Patients receiving the combination can require closer anticoagulation monitoring.
Lithium also deserves attention because concomitant treatment can increase the risk of lithium toxicity. Lithium levels, renal function and electrolytes may require monitoring when the combination cannot be avoided.
| Medicine or group | Main concern |
|---|---|
| Warfarin | Can increase anticoagulant effect and bleeding risk |
| Lithium | Can increase lithium exposure and toxicity |
| Busulfan | Potential increase in busulfan concentrations and toxicity |
| Phenytoin | Can alter metronidazole or phenytoin exposure |
| Phenobarbital | Can increase metabolism of metronidazole |
| Cyclosporine | Potential increase in cyclosporine exposure |
| Tacrolimus | Can require additional clinical monitoring |
| 5-fluorouracil | Reduced clearance can increase toxicity |
| QT-prolonging medicines | Additional concern about cardiac rhythm |
| Disulfiram | Combination requires avoidance or specific medical review |
A complete review should include prescription medicines, non-prescription products, vitamins, herbal preparations and medicines used only occasionally.
Laboratory testing can also be affected. Metronidazole may interfere with some laboratory assays, including selected measurements of liver enzymes, triglycerides and glucose, so a patient having blood work should mention current treatment.
Frequently Asked Questions
Is Flagyl the Same as Metronidazole?
Metronidazole is the active medicinal ingredient, while Flagyl is a brand name used for products containing that ingredient.
Canadian pharmacies can dispense oral metronidazole from other manufacturers, so receiving a package without the Flagyl name does not mean that the active drug has changed.
Is Metronidazole a Strong Antibiotic?
“Strong” does not accurately describe how antibiotics are selected. Metronidazole is particularly useful against susceptible anaerobic bacteria and several protozoa but provides little or no useful activity against many organisms treated by other antibiotic classes.
An antibiotic can therefore be highly effective for one infection and inappropriate for another. The organism and infection site are more useful considerations than ranking medicines as stronger or weaker.
Can Flagyl Treat a UTI?
Metronidazole is not a standard treatment for most uncomplicated bacterial urinary tract infections because the organisms commonly responsible for UTIs usually require other antibacterial coverage.
Some conditions involving the genital or urinary area, including trichomoniasis, can produce symptoms that resemble a urinary infection. Diagnosis therefore matters before treatment is selected.
Does Metronidazole Treat Yeast Infections?
No. Vaginal yeast infections are generally caused by Candida species, which are fungi. Metronidazole acts against susceptible bacteria and protozoa and is not an antifungal medicine.
Yeast symptoms can sometimes appear during or after antibiotic treatment because changes in bacterial flora allow fungal overgrowth to become more noticeable.
Why Does Metronidazole Leave a Metallic Taste?
Taste disturbance is a recognized adverse effect of oral metronidazole and commonly presents as a metallic or otherwise unpleasant taste. Dry mouth and tongue discoloration can accompany it.
The symptom alone does not usually indicate excessive dosing or treatment failure.
Is Dark Urine Dangerous During Treatment?
Metronidazole metabolites can cause urine to appear darker, and this effect by itself generally has no clinical significance.
Dark urine accompanied by jaundice, severe abdominal pain, pale stool or pronounced weakness deserves medical assessment because those symptoms can indicate a liver problem.
Can Metronidazole Be Used for Dental Infections?
Metronidazole can be useful in dental infections where anaerobic bacteria play an important role, and it may sometimes be combined with another antibiotic to broaden bacterial coverage.
A dental abscess can also require drainage, root canal treatment, extraction or another procedure, so antibiotics do not replace treatment of the underlying dental source.
Does Flagyl Treat C. difficile Infection?
Metronidazole was historically used extensively for Clostridioides difficile infection, but current treatment approaches often give preference to other medicines in many patients.
A current episode or recurrence should therefore be treated according to present infection-specific recommendations instead of automatically using an older Flagyl regimen.
Do Sexual Partners Need Treatment?
The answer depends on the diagnosis.
With trichomoniasis, partner treatment is important because an untreated partner can transmit the parasite again and cause reinfection.
Bacterial vaginosis has traditionally followed different partner-management recommendations. The two conditions should therefore not be treated as equivalent simply because both can involve metronidazole.
What If Symptoms Continue After the Last Dose?
Persistent symptoms do not automatically mean that another identical course is required.
Possible explanations include:
- the original organism was not susceptible;
- the initial diagnosis was incorrect;
- another organism is present;
- reinfection occurred;
- a sexual partner requires treatment;
- another antibiotic or procedure is required;
- the infection has resolved while local symptoms remain temporarily.
Repeat testing or a different diagnostic approach can be more useful than increasing the dose independently.
Can You Take Metronidazole for Giardia After Travel?
Metronidazole is an established treatment option for giardiasis, and oral regimens for Giardia commonly last several days.
Travel-associated diarrhea should not automatically be assumed to be giardiasis because bacterial infections, viruses and other parasites can produce similar symptoms and require different treatment.
Can Metronidazole and Mebendazole Be Taken Together?
This combination deserves particular caution. Simultaneous exposure to mebendazole and metronidazole has been associated with concern about severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
A patient using or recently prescribed metronidazole should therefore tell the prescriber before beginning mebendazole.
What Happens If You Stop the Antibiotic Early?
Stopping treatment simply because symptoms improve can leave the original infection inadequately treated. Metronidazole should generally be taken for the prescribed duration unless the healthcare professional changes the regimen.
A serious adverse reaction is a different situation. Severe rash, new neurologic symptoms, major allergic symptoms or another important reaction can require treatment to be stopped and medically assessed.
Can Leftover Flagyl Be Used for Another Infection?
Leftover metronidazole should not be treated as a general-purpose antibiotic supply.
The regimens used for bacterial vaginosis, trichomoniasis, giardiasis, amebiasis and serious anaerobic infections differ substantially. Similar symptoms at another time also do not establish that the same organism is responsible.